Archive:New developments

• New Developments in Alzheimer’s Disease Therapeutics

  R. Scott Turner, PhD, MD Memory Disorders Program, MedStar Georgetown University Hospital Nov. 18, 2021 Aducanumab (Aduhelm®) On June 7, 2021 the FDA granted accelerated approval of the anti

  Categories: Aducanumab, New developments, News